Hologic, Inc. is an American

medical technology Health technology is defined by the World Health Organization as the "application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures, and systems developed to solve a health problem and improve quality of liv ...

company primarily focused on

women's health Women's health is an example of population health, where health is defined by the World Health Organization (WHO) as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity". Often treated ...

; it sells

medical device A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assura ...

s for

diagnostics Diagnosis (: diagnoses) is the identification of the nature and cause of a certain phenomenon. Diagnosis is used in a lot of different disciplines, with variations in the use of logic, analytics, and experience, to determine " cause and effect". ...

surgery Surgery is a medical specialty that uses manual and instrumental techniques to diagnose or treat pathological conditions (e.g., trauma, disease, injury, malignancy), to alter bodily functions (e.g., malabsorption created by bariatric surgery s ...

, and

medical imaging Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Medical imaging seeks to revea ...

History

In late November 2013, activist investor

Carl Icahn Carl Celian Icahn (; born February 16, 1936) is an American businessman and investor. He is the founder and controlling shareholder of Icahn Enterprises, a public company and diversified conglomerate holding company based in Sunny Isles Beach, ...

disclosed a 12.5% stake in the company. Subsequently, the company adopted a poison pill to prevent a hostile takeover. In negotiations with the company's board of directors, two additional directors backed by Icahn were added to the board, each managing directors of Icahn holding companies. Icahn considered his investment and intervention into Hologic to have been a success, with his nominees to the board of directors resigning on March 3, 2016 and exiting his position by May 16, 2016. In 2017, Hologic acquired Westford,

Massachusetts Massachusetts ( ; ), officially the Commonwealth of Massachusetts, is a U.S. state, state in the New England region of the Northeastern United States. It borders the Atlantic Ocean and the Gulf of Maine to its east, Connecticut and Rhode ...

-based

aesthetic medicine Aesthetic medicine is a branch of modern medicine that focuses on altering natural or acquired unwanted appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, ...

company Cynosure for $1.65 billion. On November 20, 2019, Hologic announced the

divestment In finance and economics, divestment or divestiture is the reduction of some kind of asset for financial, ethical, or political objectives or sale of an existing business by a firm. A divestment is the opposite of an investment. Divestiture is a ...

of Cynosure to

Clayton, Dubilier & Rice Clayton, Dubilier & Rice, LLC (CD&R) is an American private equity company. CD&R is the 24th oldest private equity firm in the world. CD&R has managed the investment of more than $30 billion in approximately 90 businesses, representing a bro ...

for $205 million; this was completed on December 30, 2019. Cynosure had ~825 employees at the time of the divestiture. In March 2020, Hologic received emergency use authorization from the FDA for a test for

SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the Novel coronavirus, provisional nam ...

to help mitigate the

COVID-19 pandemic The COVID-19 pandemic (also known as the coronavirus pandemic and COVID pandemic), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began with an disease outbreak, outbreak of COVID-19 in Wuhan, China, in December ...

. In May 2020, Hologic received a second emergency use authorization from the FDA for 2019-nCov to increase potential throughput of testing. In June 2020, Hologic collaborated with

Grifols Grifols, S.A. () is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a d ...

, a global producer of plasma-driven medicines, to increase Spain's testing capacity for COVID-19. In November 2020, Hologic won a $119 million contract from the

U.S. Department of Health and Human Services The United States Department of Health and Human Services (HHS) is a cabinet-level executive branch department of the US federal government created to protect the health of the US people and providing essential human services. Its motto is "Im ...

and the

Department of Defense The United States Department of Defense (DoD, USDOD, or DOD) is an executive department of the U.S. federal government charged with coordinating and supervising the six U.S. armed services: the Army, Navy, Marines, Air Force, Space Force, ...

to help expand production facilities in three states, Wisconsin, Maine, and California, with the goal to provide 13 million COVID tests per month by January 2022. In January 2021, the company announced it would acquire Biotheranostics and its breast and metastatic cancer test portfolio for $230 million and SOMATEX for $64 Million. In April 2021, the company announced it will acquire Mobidiag, a molecular diagnostics firm with multiplex technology, for $795 million. The acquisition completed in June 2021. In March 2022, Hologic became the

title sponsor Naming rights are a financial transaction and form of advertising or memorialization where a corporation, person, or other entity purchases the right to name a facility, object, location, program, or event (most often sports venues), typical ...

of the

WTA Tour The WTA Tour (also known as the Hologic WTA Tour for sponsorship reasons) is a worldwide top-tier tennis tour for women and organized by the Women's Tennis Association. The second-tier tour is the WTA 125 series, and third-tier is the ITF Wome ...

in women's professional tennis. As part of the sponsorship, the company was also named the "official health partner" of the

Women's Tennis Association The Women's Tennis Association (WTA) is the principal organizing body of women's professional tennis. The association governs the WTA Tour, which is the worldwide professional tennis tour for women, and was founded to create a better future fo ...

. In April 2024, Hologic agreed to acquire British medical device manufacturer Endomag for $310 million. The acquisition completed in July that year. In 2025, Hologic acquired Gynesonics for $350 million, which developed the Sonata System, an ultrasound imaging device for

uterine fibroids Uterine fibroids, also known as uterine leiomyomas, fibromyoma or fibroids, are leiomyoma, benign smooth muscle tumors of the uterus, part of the female reproductive system. Most people with fibroids have no symptoms while others may have dysm ...

References

External links

* {{Authority control American companies established in 1985 Companies based in Middlesex County, Massachusetts Companies listed on the Nasdaq Health care companies based in Massachusetts Health care companies established in 1985 Marlborough, Massachusetts Medical technology companies of the United States